M4 muscarinic AChR agonists (Sumitomo Dainippon Pharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameM4 muscarinic AChR agonists (Sumitomo Dainippon Pharma)
Drug Alias NameM4 muscarinic AChR agonists (Dainippon Sumitomo Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 agonists
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsPsychotic DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A